Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectives
about
Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer CellsPharmacologic resistance in colorectal cancer: a reviewTargeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancer in vivo and in vitro through elevating p21 and ROS levels.Upregulated SLC1A5 promotes cell growth and survival in colorectal cancerAntagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical studySenescence of tumor cells induced by oxaliplatin increases the efficiency of a lipid A immunotherapy via the recruitment of neutrophils.May CTC technologies promote better cancer management?Potentiating effects of GHRH analogs on the response to chemotherapy.New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor.New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones.Universal screening test based on analysis of circulating organ-enriched microRNAs: a novel approach to diagnostic screening.Assessing tumor angiogenesis in colorectal cancer by quantitative contrast-enhanced endoscopic ultrasound and molecular and immunohistochemical analysis.Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment.Isolating epidermal growth factor receptor overexpressing carcinoma cells from human whole blood by bio-ferrography.Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6.Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells.The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States.
P2860
Q26751018-C9476DE0-2374-4154-A76F-3189E13B7349Q26769850-5053860A-902B-414E-AD5B-4A3C89C1112BQ34101055-CA0A8664-F434-4428-8B5E-117325844BE9Q34371526-D3DB924B-6856-48C6-A3CD-6E901E70072BQ34781112-A8BDB962-AA28-4C29-9454-E66B6552942BQ34956634-90D2D599-1CDA-4671-B2D8-6EC09F12AEEFQ35016353-84116940-6D93-42A2-AB98-70C646665E96Q35565027-45576DB2-7EEA-4C33-BC34-2065B5CCD549Q35833122-2CBACB93-B3DF-42C0-B58D-DE26B58F3F54Q36748502-343492B5-1686-4F75-89FB-785788A42E6FQ38263664-4880D5B5-5017-458B-A44B-579C8329A4B9Q38689833-6099571B-D2A9-495E-9924-F98C61B66AF0Q38776596-76A472BF-9AFB-4DDF-8EF3-0E3A255D6707Q42832461-D57DCFA2-FBBF-40F7-B98F-34CC918974D6Q47280262-95FEAEEB-2FFD-46DC-9D2E-F4F6189710CBQ50865530-AF54EAB9-1DA3-4030-88AE-B0C5B60BBDE5Q51459332-88C557DD-D044-4AB8-888A-D8040877F949
P2860
Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectives
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeted therapy in advanced m ...... rent concepts and perspectives
@en
type
label
Targeted therapy in advanced m ...... rent concepts and perspectives
@en
prefLabel
Targeted therapy in advanced m ...... rent concepts and perspectives
@en
P2093
P2860
P356
P1476
Targeted therapy in advanced m ...... rent concepts and perspectives
@en
P2093
Florian Hohla
Norman L Block
Richard Greil
Thomas Winder
P2860
P304
P356
10.3748/WJG.V20.I20.6102
P407
P577
2014-05-01T00:00:00Z